🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aimed to evaluate the efficacy and safety of SKB264 combined wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07109284
Treatments Being Tested
This is a Phase II single-arm study designed to evaluate the efficacy and s...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-13
Trial ID
NCT07258108
Treatments Being Tested
This is an open-label, single-arm, multicenter phase II study to evaluate t...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-09-01
Trial ID
NCT07153965
Treatments Being Tested
This is a single-arm, multi-center phase II study to evaluate the efficacy ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-08-31
Trial ID
NCT07701681
Treatments Being Tested
The goal of this clinical trial is to evaluate the anti-tumor activity, saf...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-05-11
Trial ID
NCT07492914
Treatments Being Tested
This study is a prospective, single arm II clinical trial. The main objecti...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2025-09-22
Trial ID
NCT07179783
Treatments Being Tested
In recent years, substantial progress has been made in the development of p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-15
Trial ID
NCT07108816
Treatments Being Tested
This is a prospective, open-label, multicenter, single-arm Phase II study d...
Status
Not Yet Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-09-01
Trial ID
NCT07738757
Treatments Being Tested
This is a multicenter, open-label, multiple-dose dose finding and expansion...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2022-03-16
Trial ID
NCT05367635
Treatments Being Tested